Straumann’s turnover from July to September was CHF 550.5 million. That’s 10.9 percent more than a year ago, as the company announced Wednesday. Organically, excluding acquisitions and currency effects, growth was 12.2 percent. Analysts had expected slightly lower values.
In the first half of the year, organic sales increased by 20.8 percent. Straumann does not disclose earnings figures for the third quarter.
Referring to the summer holidays in many countries in the northern hemisphere, Straumann explained that the third quarter of the year has traditionally been somewhat weaker. However, the improvement “continues to be strong” compared to the previous year and patient demand is still “good”.
However, the weaker economic and consumer environment did not leave Straumann unscathed. For example, “macroeconomic developments” in the North American region, though less strong than in the second quarter, have driven down demand for dental splints. Those who have to shoulder high prices often do without the so-called “aligners”.
In terms of regions, Straumann has grown strongly everywhere, but especially in Latin America. The increase there increased by 20.9 percent to CHF 47.9 million. In the largest region, “Europe, Middle East and Africa”, it increased by 15.1% and reached 218.5 million.
Looking ahead, Straumann raises its forecast for the current year. Straumann is now targeting organic growth in the mid-range instead of the low double-digit percentage range as before.
For comparison: Straumann reported 18.0 percent organic sales growth for the first nine months. Profitability should be around 26 percent (2021: 26.8%).
(SDA)